Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology ; volume:12 ; number:3 ; year:2020 ; extent:18
EMBO molecular medicine / European Molecular Biology Organization ; 12, Heft 3 (2020) (gesamt 18)
- Urheber
-
Sierksma, Annerieke
Lu, Ashley
Mancuso, Renzo
Fattorelli, Nicola
Thrupp, Nicola
Salta, Evgenia
Zoco, Jesus
Blum, David
Buée, Luc
De Strooper, Bart
Fiers, Mark
- DOI
-
10.15252/emmm.201910606
- URN
-
urn:nbn:de:101:1-2022070408044236501024
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sierksma, Annerieke
- Lu, Ashley
- Mancuso, Renzo
- Fattorelli, Nicola
- Thrupp, Nicola
- Salta, Evgenia
- Zoco, Jesus
- Blum, David
- Buée, Luc
- De Strooper, Bart
- Fiers, Mark
Ähnliche Objekte (12)
Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
Copper mediated amyloid-β binding to Transthyretin
LRP1 plays a major role in the amyloid-β clearance in microglia
Origins of amyloid-β
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology
Selective amyloid-β lowering agents
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Amyloid-β and synapse-to-nucleus signaling in neurodegenerative diseases
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
Amyloid-β with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation
Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
Copper mediated amyloid-β binding to Transthyretin
LRP1 plays a major role in the amyloid-β clearance in microglia
Origins of amyloid-β
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology
Selective amyloid-β lowering agents
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Amyloid-β and synapse-to-nucleus signaling in neurodegenerative diseases
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies
Amyloid-β with isomerized Asp7 cytotoxicity is coupled to protein phosphorylation
Enriched environment enhances β‐adrenergic signaling to prevent microglia inflammation by amyloid‐β
Copper mediated amyloid-β binding to Transthyretin
LRP1 plays a major role in the amyloid-β clearance in microglia
Origins of amyloid-β
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related amyloid-β pathology
Selective amyloid-β lowering agents
Soluble aggregates of the amyloid-β peptide are trapped by serum albumin to enhance amyloid-β activation of endothelial cells
Amyloid-β and synapse-to-nucleus signaling in neurodegenerative diseases
Attenuated amyloid-β aggregation and neurotoxicity owing to methionine oxidation
Development of conformation specific Amyloid-β [Amyloid-beta] antibodies